Collectly's AI Agent and RCM Platform for Patient Billing Now Available in Connection Hub on Epic Showroom

Collectly announced its AI-powered patient billing and RCM platform is now available in Epic’s Connection Hub via a bidirectional Epic integration for 3,000+ healthcare facilities. The company claims it can compress time-to-collect to under two weeks, resolve 475,000+ billing questions via its AI agent Billie, and reduce billing-support overhead by up to 85%, aiming to address leakage as patient responsibility rises from ~5% of revenue in 2010 to ~20% today (projected 30% by decade-end). Impact is likely incremental for providers adopting the integration rather than a broad market mover.

Analysis

This is more a validation point for the AI-RCM adoption curve than a near-term earnings event. The first-order beneficiary is the private software layer that sits on top of Epic; the public-market read-through is modestly negative for labor-heavy billing services and legacy patient-finance workflows if agentic triage demonstrably reduces cost-to-collect, but the benefit is likely to accrue slowly as hospital CFOs demand proof on cash acceleration and denial reduction before broad rollout.

The second-order risk is that adoption is constrained by integration friction, compliance review, and the fact that many provider organizations will pilot on a narrow slice of balances before touching core workflows. That means the immediate revenue impact on public comps is probably de minimis; the bigger implication is 6-18 months out, when a few large Epic health systems standardize on AI agents and manual statement/call-center spend becomes a budget line to cut. If that happens, outsourced patient-service vendors and traditional RCM suites could face pricing pressure even if collection rates improve.

Contrarian angle: the market may be overrating how much of the patient-responsibility problem is solvable with software alone. Automation can reduce friction and staff load, but it does not change affordability, and the hardest-to-collect balances are usually the least responsive to digital nudges; that caps the upside to cash conversion and makes the gross margin story more compelling than the top-line story. Near term, there is no obvious public-equity catalyst unless a listed competitor or customer explicitly quantifies uplift in cost-to-collect or free cash flow.

Key Decisions for Investors

• No immediate trade: treat this as a monitoring item, not a catalyst-driven position, until a public RCM vendor or large Epic customer quantifies cash collection uplift and support-cost reduction in earnings or guidance.
• Watch WAY as the cleanest public proxy for AI-enabled RCM workflows; if management commentary turns defensive on pricing or implementation velocity over the next 1-2 quarters, consider a tactical short against stronger healthcare IT names.
• If evidence emerges that large Epic health systems are scaling AI billing agents beyond pilots, pair long high-quality healthcare software/platform names with short labor-intensive RCM service exposure; the best expression would be long quality SaaS / short RCM-beta, but only after hard adoption data.
• Set an alert on any disclosure of reduced cost-to-collect or lower call-center volume from Epic-native providers; a 100-200 bps improvement in collection efficiency would be enough to re-rate niche RCM vendors, but absent that, the move is likely overhyped.
• For now, avoid chasing the AI-healthcare narrative broadly here; the better risk/reward is to wait for a public-market confirmation event rather than pay up for a thematic read-through.